- Southern Cross Equities has updated it's research on Mesoblast (MSB) with a Buy recommendation
- Report dated 03/03/2011
- 12 month price target increased from $7 to $11.
- MSB last trade: $6.33 (04/03/2011)
- Research link
Showing posts with label Mesoblast (MSB). Show all posts
Showing posts with label Mesoblast (MSB). Show all posts
Sunday, March 6, 2011
Mesoblast Research Report
Subscribe to:
Posts (Atom)